carbamates has been researched along with Cortical Lewy Body Disease in 20 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "The aim of this analysis of the effects of cholinergic therapy in dementia with Lewy bodies was to determine whether rivastigmine-induced benefits in attention and memory could be predicted by the presence of visual hallucinations." | 9.11 | Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies. ( Ferrara, R; McKeith, IG; Perry, E; Wesnes, KA, 2004) |
| "The aim of this analysis of the effects of cholinergic therapy in dementia with Lewy bodies was to determine whether rivastigmine-induced benefits in attention and memory could be predicted by the presence of visual hallucinations." | 5.11 | Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies. ( Ferrara, R; McKeith, IG; Perry, E; Wesnes, KA, 2004) |
| " Testing was conducted prior to dosing and then again at weeks 12, 20 and 23." | 2.70 | Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system. ( Anand, R; Cicin-Sain, A; Del Ser, T; Emre, M; Ferrara, R; McKeith, IG; Spano, PF; Spiegel, R; Wesnes, KA, 2002) |
| "Treatment with donepezil and rivastigmine (successively) did not produce the desired benefits." | 1.32 | A case study in the treatment of dementia with Lewy bodies. ( Kaufer, DI, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 19 (95.00) | 29.6817 |
| 2010's | 1 (5.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fujishiro, H | 1 |
| Scheepmaker, AJ | 1 |
| Horstink, MW | 1 |
| Hoefnagels, WH | 1 |
| Strijks, FE | 1 |
| Moerkens, RM | 1 |
| Dhondt, AD | 1 |
| Mol, JA | 1 |
| Wild, R | 1 |
| Pettit, T | 1 |
| Burns, A | 1 |
| Kaufer, DI | 2 |
| de Brito-Marques, PR | 1 |
| de Mello, RV | 1 |
| Montenegro, L | 1 |
| McKeith, IG | 5 |
| Wesnes, KA | 2 |
| Perry, E | 1 |
| Ferrara, R | 4 |
| Sagi, Y | 1 |
| Driguès, N | 1 |
| Youdim, MB | 1 |
| Grace, JB | 2 |
| Walker, Z | 2 |
| Byrne, EJ | 3 |
| Wilkinson, D | 2 |
| Stevens, T | 2 |
| Perry, EK | 1 |
| Walker, MP | 1 |
| Del Ser, T | 3 |
| McKeith, I | 2 |
| Anand, R | 3 |
| Cicin-Sain, A | 3 |
| Spiegel, R | 3 |
| Cummings, JL | 1 |
| Spano, P | 1 |
| Emre, M | 2 |
| Wesnes, K | 1 |
| Patterson, C | 1 |
| Hogan, DB | 1 |
| Grace, J | 1 |
| Daniel, S | 1 |
| Shankar, KK | 1 |
| Butler, S | 1 |
| Woolford, J | 1 |
| Waite, J | 1 |
| Maclean, LE | 1 |
| Collins, CC | 1 |
| Spano, PF | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| An Open Label 24-Week, Flexible Dose Trial to Assess the Safety and Efficacy of Galantamine in Patients With Dementia With Lewy Bodies[NCT00230997] | Phase 3 | 50 participants | Interventional | 2002-12-31 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
3 reviews available for carbamates and Cortical Lewy Body Disease
| Article | Year |
|---|---|
Cholinesterase inhibitors for dementia with Lewy bodies.
Topics: Aged; Carbamates; Cholinesterase Inhibitors; Humans; Lewy Body Disease; Phenylcarbamates; Randomized | 2003 |
Brief review: rivastigmine, a second cholinesterase inhibitor.
Topics: Aged; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Humans; Lewy Body Disease; Neuroprot | 2001 |
Understanding changes in cholinergic function: implications for treating dementia.
Topics: Activities of Daily Living; Alzheimer Disease; Carbamates; Cholinergic Fibers; Cholinesterase Inhibi | 2002 |
6 trials available for carbamates and Cortical Lewy Body Disease
| Article | Year |
|---|---|
Hallucinations predict attentional improvements with rivastigmine in dementia with lewy bodies.
Topics: Aged; Attention; Carbamates; Disease Progression; Double-Blind Method; Female; Hallucinations; Human | 2004 |
Rivastigmine in the treatment of dementia with Lewy bodies: preliminary findings from an open trial.
Topics: Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Cognition Disorders; Drug Tolerance; | 2000 |
Dementia with lewy bodies: findings from an international multicentre study.
Topics: Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Female; Humans; Lewy Body Disease; M | 2000 |
Efficacy of rivastigmine in dementia with Lewy bodies: a randomised, double-blind, placebo-controlled international study.
Topics: Aged; Carbamates; Cholinesterase Inhibitors; Double-Blind Method; Female; Humans; Lewy Body Disease; | 2000 |
Long-Term use of rivastigmine in patients with dementia with Lewy bodies: an open-label trial.
Topics: Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Cognition; Female; Humans; Lewy Body | 2001 |
Effects of rivastigmine on cognitive function in dementia with lewy bodies: a randomised placebo-controlled international study using the cognitive drug research computerised assessment system.
Topics: Aged; Carbamates; Diagnosis, Computer-Assisted; Double-Blind Method; Female; Follow-Up Studies; Huma | 2002 |
11 other studies available for carbamates and Cortical Lewy Body Disease
| Article | Year |
|---|---|
Effects of gabapentin enacarbil on restless legs syndrome and leg pain in dementia with Lewy bodies.
Topics: Aged; Carbamates; Dopamine Agonists; Female; gamma-Aminobutyric Acid; Hallucinations; Humans; Japan; | 2014 |
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Topics: Aged; Aged, 80 and over; Antiparkinson Agents; Antipsychotic Agents; Benzodiazepines; Carbamates; Ch | 2003 |
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Topics: Carbamates; Cholinesterase Inhibitors; Dose-Response Relationship, Drug; Humans; Lewy Body Disease; | 2003 |
[Dementia with Lewy bodies; 2 patients with exacerbation due to an atypical antipsychotic, but with a favorable response to the cholinesterase inhibitor rivastigmine].
Topics: Carbamates; Cholinesterase Inhibitors; Hospitalization; Humans; Lewy Body Disease; Neuroprotective A | 2003 |
Pharmacologic treatment expectations in the management of dementia with Lewy bodies.
Topics: Aged; Alzheimer Disease; Antipsychotic Agents; Brain; Carbamates; Cholinesterase Inhibitors; Diagnos | 2004 |
Nightmares without atonia as an early symptom of diffuse Lewy bodies disease.
Topics: Aged; Atrophy; Carbamates; Cholinesterase Inhibitors; Dreams; Fatal Outcome; Humans; Immunohistochem | 2003 |
A case study in the treatment of dementia with Lewy bodies.
Topics: Aged; Aged, 80 and over; Carbamates; Cognition Disorders; Donepezil; Drug Resistance; Female; Galant | 2004 |
The neurochemical and behavioral effects of the novel cholinesterase-monoamine oxidase inhibitor, ladostigil, in response to L-dopa and L-tryptophan, in rats.
Topics: Animals; Basal Ganglia; Behavior, Animal; Carbamates; Cholinesterase Inhibitors; Dopamine; Hippocamp | 2005 |
A comparison of sleep profiles in patients with dementia with lewy bodies and Alzheimer's disease.
Topics: Aged; Aged, 80 and over; Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Female; Humans; L | 2000 |
Cholinesterase inhibitors: expanding applications.
Topics: Alzheimer Disease; Carbamates; Cholinesterase Inhibitors; Humans; Lewy Body Disease; Phenylcarbamate | 2000 |
Dementia with Lewy bodies treated with rivastigmine: effects on cognition, neuropsychiatric symptoms, and sleep.
Topics: Aged; Aged, 80 and over; Carbamates; Cholinesterase Inhibitors; Cognition; Female; Humans; Lewy Body | 2001 |